STOCK TITAN

STIM (NASDAQ: STIM) holder Keith Sullivan plans 33,847-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

STIM shareholder Keith Sullivan filed a notice of proposed sale of 33,847 shares of common stock. The shares are expected to be sold through Fidelity Brokerage Services on NASDAQ around 02/12/2026, with an indicated aggregate market value of $55,712.16.

The 33,847 shares came from restricted stock that vested on 02/09/2026 as compensation from the issuer. The filing notes 68,485,922 common shares outstanding. Over the prior three months, Sullivan also sold 40,976 common shares for gross proceeds of $63,398.07.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the STIM Form 144 filing by Keith Sullivan disclose?

The filing discloses a planned sale of 33,847 STIM common shares. Keith Sullivan intends to sell these shares on NASDAQ through Fidelity Brokerage Services, with an indicated aggregate market value of $55,712.16, following recent restricted stock vesting.

How many STIM shares does Keith Sullivan plan to sell under this Form 144?

Keith Sullivan plans to sell 33,847 STIM common shares. These shares are listed with an aggregate market value of $55,712.16 and are expected to be sold on or about February 12, 2026, through Fidelity Brokerage Services on NASDAQ.

How were the STIM shares in the Form 144 acquired by Keith Sullivan?

The 33,847 STIM shares were acquired through restricted stock vesting. The vesting occurred on February 9, 2026, as compensation from the issuer, and that same date is shown as both the acquisition and payment date in the filing.

What recent STIM share sales has Keith Sullivan already completed?

In the past three months, Sullivan sold 40,976 STIM shares. Those earlier sales of common stock generated gross proceeds of $63,398.07, which are reported alongside the new proposed sale in the Form 144 disclosure.

How many STIM shares are reported as outstanding in this Form 144?

The filing reports 68,485,922 STIM common shares outstanding. This figure provides context for the planned 33,847-share sale, showing the proposed transaction is small relative to the total shares reported outstanding.

On which exchange and through which broker will the STIM shares be sold?

The planned STIM share sale will occur on NASDAQ via Fidelity. The Form 144 lists Fidelity Brokerage Services LLC as the broker and NASDAQ as the securities exchange for the 33,847 common shares to be sold.
Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

97.25M
34.32M
9.44%
59.08%
8.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN